P. Pootrakul

S. Fucharoen, P. Pootrakul, E. Wiener, 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Adequacy of iron supply for erythropoiesis: in vivo observations in humans.

M. Cazzola, G. Bergamaschi, P. Pootrakul, 1987, The Journal of laboratory and clinical medicine.

Clinical Manifestation of &bgr;-Thalassemia/Hemoglobin E Disease

S. Fucharoen, P. Pootrakul, N. Siritanaratkul, 2000, Journal of pediatric hematology/oncology.

Labile plasma iron (LPI) as an indicator of chelatable plasma redox activity in iron-overloaded beta-thalassemia/HbE patients treated with an oral chelator.

Z. Cabantchik, M. Sametband, P. Pootrakul, 2004, Blood.

The course of anaemia after the treatment of acute, falciparum malaria.

G. Brittenham, V. Gordeuk, S. Looareesuwan, 1998, Annals of tropical medicine and parasitology.

Impaired glucose counterregulation after insulin-induced hypoglycemia in thalassemic patients.

P. Pootrakul, S. Fucharoen, S. Vannasaeng, 1987, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

Variable severity of Southeast Asian beta 0-thalassemia/Hb E disease.

S. Fucharoen, P. Pootrakul, P. Winichagoon, 1987, Birth defects original article series.

Patients with thalassemia develop osteoporosis, osteomalacia, and hypoparathyroidism, all of which are corrected by transfusion.

J. Burnell, P. Pootrakul, C. Finch, 1987, Birth defects original article series.

Differences between two types of Hb H disease, alpha-thalassemia 1/alpha-thalassemia 2 and alpha-thalassemia 1/Hb constant spring.

S. Fucharoen, P. Pootrakul, P. Winichagoon, 1987, Birth defects original article series.

Thalassemia in Southeast Asia: Determination of Different Degrees of Severity of Anemia in Thalassemia a

P. Wilairat, S. Fucharoen, P. Pootrakul, 1985, Annals of the New York Academy of Sciences.

Determination for different severity of anemia in thalassemia: concordance and discordance among sib pairs.

S. Fucharoen, P. Pootrakul, P. Winichagoon, 1984, American journal of medical genetics.

Serum ferritin levels in thalassemias and the effect of splenectomy.

P. Pootrakul, P. Wasi, V. Vongsmasa, 1981, Acta haematologica.

A SYNDROME OF HYPERTENSION, CONVULSION, AND CEREBRAL HÆMORRHAGE IN THALASSÆMIC PATIENTS AFTER MULTIPLE BLOOD-TRANSFUSIONS

P. Pootrakul, A. Piankijagum, S. Na-nakorn, 1978, The Lancet.

Hemin: A Possible Cause of Oxidative Stress in Blood Circulation of β-Thalassemia/Hemoglobin E Disease

S. Fucharoen, S. Porasuphatana, P. Pootrakul, 2003, Free radical research.

A correlation of erythrokinetics, ineffective erythropoiesis, and erythroid precursor apoptosis in thai patients with thalassemia.

S. Schrier, L. Ma, P. Pootrakul, 2000, Blood.

Clinical trial of deferiprone iron chelation therapy in β‐thalassaemia/haemoglobin E patients in Thailand

A. Hoffbrand, S. Fucharoen, U. Kachintorn, 2003, British journal of haematology.

oral chelator -thalassemia/HbE patients treated with an β activity in iron-overloaded Labile plasma iron (LPI) as an indicator of chelatable plasma redox

I. Cabantchik, M. Sametband, P. Pootrakul, 2013 .

Effects of α-Thalassemia on Pharmacokinetics of the Antimalarial Agent Artesunate

S. Meshnick, S. Looareesuwan, P. Pootrakul, 1998, Antimicrobial Agents and Chemotherapy.

INCREASED TRANSFERRIN IRON SATURATION IN SPLENECTOMIZED THALASSAEMIC PATIENTS

P. Pootrakul, P. Wasi, R. Rugkiatsakul, 1980, British journal of haematology.

Mössbauer spectroscopic study of the forms of iron in normal human liver and spleen tissue

T. Pierre, W. Chua-anusorn, P. Pootrakul, 1994 .

Organ-specific crystalline structures of ferritin cores inβ-thalassemia/hemoglobin E

T. S. St. Pierre, B. Heywood, K. Tran, 2005, Biology of Metals.

Red cell and plasma calcium, copper and zinc in beta-thalassemia/hemoglobin E.

S. Fucharoen, P. Pootrakul, A. Likidlilid, 1991, The Southeast Asian journal of tropical medicine and public health.

Effect of thalassemia/hemoglobin E disease on macro, trace, and ultratrace element concentrations in human tissue

F. Nielsen, P. Pootrakul, T. R. Shuler, 1990 .

Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in beta-thalassemia/hemoglobin E disease.

A. Schechter, S. Fucharoen, N. Poolsup, 1996, Blood.

Labile plasma iron in iron overload: redox activity and susceptibility to chelation.

Z. Cabantchik, P. Pootrakul, W. Breuer, 2003, Blood.

Quantitation of ferritin iron in plasma, an explanation for non- transferrin iron

P. Pootrakul, C. Finch, H. Huebers, 1988 .

Role of transferrin in determining internal iron distribution.

P. Pootrakul, C. Finch, B. Josephson, 1977, Blood.

Erythroid marrow function in anemic patients.

M. Cazzola, P. Pootrakul, C. Finch, 1987, Blood.

Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin.

G. Fillet, P. Pootrakul, Y. Beguin, 1993, Blood.

Intact transferrin receptors in human plasma and their relation to erythropoiesis.

P. Pootrakul, C. Finch, Y Beguin, 1990, Blood.

High-dose intravenous immunoglobulin in the management of immune hemolysis in patients with thalassemic disease: factors which determine refractoriness.

P. Pootrakul, S. Fucharoen, W. Wanachiwanawin, 1991, The Southeast Asian journal of tropical medicine and public health.

Hemoglobin Mahidol. A clinical hematologic and genetic study.

P. Pootrakul, S. Na-nakorn, P. Wasi, 1972, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

Clinical and hematologic manifestations of AE Bart disease.

S. Fucharoen, P. Pootrakul, P. Winichagoon, 1987, Birth defects original article series.

Mineralization of iron in ferritin and haemosiderin: the effect of tissue environment on mineral structure.

T. Pierre, K. Tran, P. Pootrakul, 1991 .

Desferrioxamine-chelatable iron, a component of serum non-transferrin-bound iron, used for assessing chelation therapy.

Z. Cabantchik, P. Pootrakul, W. Breuer, 2001, Blood.

Homozygous haemoglobin constant spring: A need for revision of concept

S. Fucharoen, P. Pootrakul, P. Winichagoon, 2004, Human Genetics.

Plasma iron and transferrin iron-binding capacity evaluated by colorimetric and immunoprecipitation methods.

P. Pootrakul, C. Finch, N. Ekpoom, 1987, Clinical chemistry.

Incidence of haemoglobin Thai: a re‐examination of the genetics of α‐thalassaemic diseases

P. Pootrakul, S. Na-nakorn, P. Wasi, 1972 .

The effects of vitamin E on platelet activity in β‐thalassaemia patients

S. Fucharoen, P. Pootrakul, Supeenun Unchern, 2003 .

Iron metabolism in thalassemia.

M. Cazzola, M. Pippard, P. Pootrakul, 1988, Birth defects original article series.

The effects of vitamin E on platelet activity in b-thalassaemia

S. Fucharoen, P. Pootrakul, Supeenun Unchern, 2003 .

Clinical silent cerebral infarct (SCI) in patients with thalassemia diseases assessed by magnetic resonance imaging (MRI).

P. Pootrakul, Pichest Metarugcheep, Somsak Chanyawattiwongs, 2008, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

α‐ and β‐Thalassemia in Thailand

S. Fucharoen, P. Pootrakul, N. Siritanaratkul, 1998 .

Clinical Manifestation of -Thalassemia/Hemoglobin E Disease

Suthat Fucharoen, S. Fucharoen, P. Pootrakul, 2000 .

Non‐Transferrin Plasma Iron in β‐Thalassaemia/Hb E and Haemoglobin H Diseases

P. Pootrakul, P. Wasi, M. Anuwatanakulchai, 2009 .

Non-transferrin plasma iron in beta-thalassaemia/Hb E and haemoglobin H diseases.

P. Pootrakul, P. Wasi, M. Anuwatanakulchai, 1984, Scandinavian journal of haematology.

Pituitary function in thalassemic patients and the effect of chelation therapy.

P. Pootrakul, S. Fucharoen, S. Vannasaeng, 1991, Acta endocrinologica.

The effects of vitamin E on platelet activity in beta-thalassaemia patients.

S. Fucharoen, P. Pootrakul, Supeenun Unchern, 2003, British journal of haematology.

A prophylactic supplementation of iron and folate in pregnancy.

P. Pootrakul, O. Kiriwat, S. Areekul, 1983, Southeast Asian Journal of Tropical Medicine and Public Health.

The use of capillary blood for measurements of circulating ferritin.

J. Cook, B. Skikne, P. Pootrakul, 1983, The American journal of clinical nutrition.

Oxidative stress and antioxidants in beta-thalassemia/hemoglobin E.

S. Fucharoen, P. Pootrakul, A. Likidlilid, 1987, Birth defects original article series.

Objectives and Methods of Iron Chelation Therapy

I. Cabantchik, P. Pootrakul, W. Breuer, 2003, Bioinorganic chemistry and applications.

Development and Evaluation of a PCR-based, Line Probe Assay for the Detection of 58 Alleles in the Cystic Fibrosis Transmembrane Conductance Regulator

S. Piantadosi, P. Pootrakul, E. Magid, 2002 .

Effects of alpha-thalassemia on pharmacokinetics of the antimalarial agent artesunate.

S. Meshnick, S. Looareesuwan, P. Pootrakul, 1998, Antimicrobial agents and chemotherapy.

Glomerulonephritis in beta-thalassemia Hb-E disease: clinical manifestations, histopathologic studies and outcome.

P. Pootrakul, P. Malasit, S. Fucharoen, 1995, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

Clinical silent cerebral infarct (SCI) in patients with thalassemia diseases assessed by magnetic resonance imaging (MRI).

P. Pootrakul, Pichest Metarugcheep, Somsak Chanyawattiwongs, 2008, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.